Rising healthcare costs force millions to skip doctor visits

NEW YORK, United States (MNTV) – Rising healthcare costs in the United States are pushing more people to delay or avoid medical treatment, increasing the risk of more severe and expensive health problems later. According to recent data, more than one-third of adults skipped doctor visits in the past year because of cost pressures, while insurance premiums for families have surged more than 50 percent over the last decade.

The discussion around affordability has intensified as overall U.S. healthcare spending surpassed $5 trillion annually. Industry leaders such as Elevance Health argue that premiums reflect the broader inflation of medical services rather than direct prepayment for care. However, critics note that insurers also benefit from a highly complex system that often shifts financial burdens onto patients through rising deductibles, limited networks, and administrative barriers.

Hospital services and prescription drugs remain major drivers of spending growth, with hospital costs posting their fastest increases in decades and drug prices continuing to climb sharply. While insurers blame system inefficiencies, fraud, and regulatory complications, analysts argue that corporate consolidation among hospitals, pharmaceutical companies, and insurers has also reduced competition and contributed to escalating prices.

The report also criticizes unintended consequences of the No Surprises Act, a federal law designed to protect patients from unexpected medical bills. Executives at Elevance Health claim loopholes in the law have allowed some out-of-network providers to demand significantly higher payments, fueling disputes and potentially increasing premiums. Consumer advocates, however, argue the law remains essential because surprise billing previously exposed patients to devastating financial shocks.

Elevance Health promotes reforms focused on lower-cost treatment settings, fraud detection, and preventive care tied to social factors such as housing and food access.

Yet critics say many proposed solutions still prioritize cost management over deeper structural reform. They argue meaningful affordability will require stronger regulation of hospital pricing, tighter oversight of pharmaceutical companies, and limits on profit-driven practices across the healthcare industry.